Q1. Please provide the number of patients treated (for any condition) in the last 4 months with:
a. Ajovy (fremanezumab)
b. Aimovig (erenumab)
c. Emgality (galcanezumab)
Q2. How many of these patients were treated as part of a free or nominal charge scheme with:
a. Ajovy (fremanezumab)
b. Aimovig (erenumab)
c. Emgality (galcanezumab)
Q3. How many patients have you treated in the last 4 months for?
a. Any type of migraine
b. Chronic migraine (15+ headache days per month).
c. Episodic migraine (4+ headache days per month)
Q4. Please provide the number of migraine patients treated in the last 4 months with Botulinum Toxin (i.e. Botox, Dysport, Xeomin).
Q5. In case you do not treat chronic or episodic migraine, can you please tell us which hospital or trust you refer these patients to?
